Md. Masoom Perwez

A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19

R. Pandey, A. Lahiri, S. Chatterjee, 2022, Nature communications.

Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial

A. Tewari, M. Saha, R. Pandey, 2020, medRxiv.